Guo, YugangTang, LiZhao, Yang2023-04-032023-04-032023-04-032023https://infoscience.epfl.ch/handle/20.500.14299/196676The present invention relates generally to the field of anti-cancer therapy, in particular to the use of adoptive T cell transfer therapy for treating cancer, in particular sold tumors. More specifically, the present invention relates to immune cells comprising one or more recombinant constructs, wherein at least one recombinant construct encodes an interleukin-10, a fragment or a variant thereof.patentCN118043450KR20240049813AU2022334870WO2023025788CA322853677499640